BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37285135)

  • 1. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
    Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
    JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
    Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
    JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
    van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
    Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.
    O'Connell KA; Thomas JL; Murad F; Zhou G; Sonpavde GP; Mossanen M; Clinton TN; Ji-Xu A; Alton K; Spiess PE; Rossi AM; Schmults CD
    J Urol; 2024 Jan; 211(1):90-100. PubMed ID: 37788015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall Survival After Mohs Surgery for Early-Stage Merkel Cell Carcinoma.
    Cheraghlou S; Doudican NA; Criscito MC; Stevenson ML; Carucci JA
    JAMA Dermatol; 2023 Oct; 159(10):1068-1075. PubMed ID: 37610773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross-sectional study.
    Doi R; Baba N; Kato H; Nakamura M; Matsushita S; Aoki M; Fujimoto N; Kato T; Iino S; Saito S; Yasuda M; Asai J; Ishikawa M; Yatsushiro H; Kawahara Y; Inafuku K; Matsuya T; Araki R; Teramoto Y; Hasegawa M; Nakama T; Nakamura Y
    Exp Dermatol; 2023 Oct; 32(10):1682-1693. PubMed ID: 37395158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of intermediate-risk squamous cell carcinoma treated with Mohs micrographic surgery compared with wide local excision.
    Udkoff J; Beal BT; Brodland DG; Knackstedt T
    J Am Acad Dermatol; 2022 Feb; 86(2):303-311. PubMed ID: 34363906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Squamous Cell Carcinoma of the Lip Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
    Nadir U; Le K; Shi K; Srivastava D; Nijhawan RI
    Dermatol Surg; 2023 Dec; 49(12):1108-1111. PubMed ID: 37910651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database.
    Singh B; Qureshi MM; Truong MT; Sahni D
    J Am Acad Dermatol; 2018 Jul; 79(1):126-134.e3. PubMed ID: 29408552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual.
    Karia PS; Morgan FC; Califano JA; Schmults CD
    JAMA Dermatol; 2018 Feb; 154(2):175-181. PubMed ID: 29261835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Margin Control of Microcystic Adnexal Carcinoma After Mohs Micrographic Surgery Compared With Wide Local Excision.
    Yerneni S; Murad F; Schmults CD; Ruiz ES
    Dermatol Surg; 2023 Apr; 49(4):317-321. PubMed ID: 36716422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins.
    Ruiz ES; Koyfman SA; Que SKT; Kass J; Schmults CD
    J Am Acad Dermatol; 2020 Feb; 82(2):420-429. PubMed ID: 31349042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
    Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
    J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients.
    Oh Y; Kim J; Zheng Z; Kim SK; Chung KY; Roh MR
    J Dermatol; 2020 Jan; 47(1):72-77. PubMed ID: 31674043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
    Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.